S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin

Biochemical and Biophysical Research Communications

Volumn 423, Issue 4, 2012, Pages 647-653

  Lee, Young ^a   Jang, Sunhyae ^a   Min, Jeong Ki ^b,c   Lee, Kyungmin ^b,c   Sohn, Kyung Cheol ^a   Lim, Jong Soon ^d   Im, Myung ^a   Lee, Hae Eul ^a   Seo, Young Joon ^a   Kim, Chang Deok ^a   Lee, Jeung Hoon ^a  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c University of Science and Technology (UST)   (South Korea)

^d Daejeon University   (South Korea)

Author keywords

Angiogenesis; Chemotactic factor; Keratinocytes; Psoriasis; S100A8; S100A9

Indexed keywords

ADENOVIRUS VECTOR; CALGRANULIN A; CALGRANULIN B; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMIS; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PSORIASIS; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

CALGRANULIN A; CALGRANULIN B; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DERMIS; ENDOTHELIAL CELLS; EPIDERMIS; HEK293 CELLS; HUMANS; JURKAT CELLS; KERATINOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN MULTIMERIZATION; PSORIASIS;

ADENOVIRIDAE;

EID: 84863815491     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.162     Document Type: Article

References (22)

1. Nickoloff B.J., Nestle F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest. 2004, 113:1664-1675.
2. Zenz R., Eferl R., Kenner L., et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369-375.
3. Foell D., Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease, Arthritis. Rheum. 2004, 50:3762-3771.
4. Benoit S., Toksoy A., Ahlmann M., et al. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br. J. Dermatol. 2006, 155:62-66.
5. Nukui T., Ehama R., Sakaguchi M., et al. a key mediator for positive feedback growth stimulation of normal human keratinocytes. J. Cell. Biochem. 2008, 104:453-464.
6. Lee Y.S., Sohn K.C., Kim K.H., et al. Role of protein kinase C delta in X-ray-induced apoptosis of keratinocyte. Exp. Dermatol. 2009, 18:50-56.
7. Kwon Y.G., Min J.K., Kim K.M., Lee D.J., Billiar T.R., Kim Y.M. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem. 2001, 276:10627-10633.
8. Min J.K., Cho Y.L., H Choi J. Receptor activator of nuclear factor (NF)-κB ligand (RANKL) increases vascular permeability; Impaired permeability and angiogenesis in eNOS-deficient mice. Blood 2007, 109:1495-1502.
9. Bhattacharya S., Bunick C.G., Chazin W.J. Target selectivity in EF-hand calcium binding proteins. Biochim. Biophys. Acta 2004, 1742:69-79.
10. Albanesi C., De Pità O., Girolomoni G. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin. Dermatol. 2007, 25:581-588.
11. Wang H., Peters T., Kess D., et al. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J. Clin. Invest. 2006, 116:2105-2114.
12. Stratis A., Pasparakis M., Rupec R.A., et al. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J. Clin. Invest. 2006, 116:2094-2104.
13. Creamer D., Sullivan D., Bicknell R., Barker J. Angiogenesis in psoriasis. Angiogenesis 2002, 5:231-236.
14. Heidenreich R., Rocken M., Ghoreschi K. Angiogenesis: the new potential target for the therapy of psoriasis?. Drug News. Perspect 2008, 21:97-105.
15. Wolf R., Lewerenz V., Büchau A.S., Walz M., Ruzicka T. Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium. Exp. Dermatol. 2007, 16:685-691.
16. Schon M.P., Boehncke W.H. Psoriasis. N. Engl. J. Med. 2005, 352:1899-1912.
17. Lim S.Y., Raftery M.J., Goyette J., Hsu K., Geczy C.L. Oxidative modifications of S100 proteins: functional regulation by redox. J. Leukocyte Biol. 2009, 86:577-587.
18. Eue I., König S., Pior J., Sorg C. S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells. Int. Immunol. 2002, 14:284-297.
19. Lee C.C., Liu K.J., Chen L.L., Wu Y.C., Huang T.S. Tumor Necrosis Factor-α,Interleukin-8 and Interleukin-6 Are Involved in Vascular Endothelial Cell Capillary Tube and Network Formation Induced by Tumor-Associated Macrophages. J. Cancer Mol. 2006, 2:155-160.
20. Gillitzer R., Ritter U., Spandau U., Goebeler M., Bröcker E.B. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J. Invest. Dermatol. 1996, 107:778-782.
21. Strieter R.M., Belperio J.A., Keane M.P. CXC chemokines in angiogenesis related to pulmonary fibrosis. Chest. 2002, 122:298S-301S.
22. Rychman C., Vandal K., Rouleau P., Talbot M., Tessier P.A. Proinflammatory activities of S100: proteins S100A8 S100A9 and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 2003, 170:3233-3242.